14-3-3 beta/alpha RNAi (H00007529-R02)

14-3-3 beta/alpha RNAi

100% Guarantee This product is fully covered under the Novus guarantee+ Policy. Click here for details.

Distributor Data...

Loading Ajax
Loading...
Loading...
 
Bulk Request
14-3-3 beta/alpha RNAi Summary:
Species:Hu
Gene:YWHAB
Specificity:Homo sapiens tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide (YWHAB), transcript variant 2, mRNA
Publications:Antibody has at least 4 Background References.
Note: Not all species have been tested for usefulness with this product. Only those species listed have been tested. We cannot make any guarantees about additional reactivities which may or may not occur.
View Additional 14-3-3 beta/alpha Products
Applications:
Unit Size:20 nmol (also available: 10 nmol)
Concentration:Concentration is not relevant for this product. Please see the protocols for proper use of this product.
Notes:
This product is produced by and distributed for Abnova, a company based in Taiwan.
Packaging:
Storage:Aliquot and store at -20 °C or -80 °C. Avoid freeze-thaw cycles.
Limitations:This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months.
Gene Symbol: YWHAB
Entrez7529 (Human)
 
Background:

Position of the Chimera RNAi. The related RNAi products listed were designed from different accesion number but sharing the same RNAi sequence. Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene.  The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo.  Chimera RNAi has many advantages over the conventional siRNAs.  First, it has been demonstrated to have reliable knock-down for over 10,000 human genes.  Because the human genome is composed of an intricate, genetic network, chimera RNAi's unique design has successfully obviated the off-target effects including microRNA-based influence.  Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected.  Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.

Images (1)
Reviews (0)
Related Products (21)
Exploring 14-3-3 beta/alpha
Working with 14-3-3 beta/alpha
Jump to: Lysates, Peptides and Proteins, Primary Antibodies, RNAi

Related Products

Lysates (2)
NameCatalog#ReactivityApplicationsImagesPublicationsReviews
14-3-3 beta/alpha LysateNBL1-17947WB(1)

14-3-3 beta/alpha LysateNBL1-17946WB(1)

Peptides and Proteins
NameCatalog#ReactivityApplicationsImagesPublicationsReviews
14-3-3 beta/alpha Recombinant ProteinH00007529-P01HuELISA, WB(1)

Primary Antibodies (11)
NameCatalog#ReactivityApplicationsImagesPublicationsReviews
14-3-3 beta/alpha Antibody (Y62)NB110-55434Hu, Mu, RtFACS, ICC, IHC-P, IP, WB(3)(1)

14-3-3 beta/alpha Antibody (E58)NB110-55435Hu, Mu, RtFACS, IHC-P, WB(3)(2)

14-3-3 beta/alpha AntibodyNBP1-35254Hu, Mu, RtIHC-P, WB(1)

14-3-3 beta/alpha AntibodyNBP1-33454HuIF, WB(2)

14-3-3 beta/alpha Antibody (2G6-3F2)H00007529-M01HuELISA, IF, WB(2)

... and 6 more. See All »
RNAi (2)
NameCatalog#ReactivityApplicationsImagesPublicationsReviews
14-3-3 beta/alpha RNAiH00007529-R01Hu(1)(4)


Jump to: Novus Explorer, Research Areas

14-3-3 beta/alpha in Context


Research Areas related to 14-3-3 beta/alpha (1):
Novus Explorer for 14-3-3 beta/alpha gene

Try our bioinformatic tool that shows the relationships between YWHAB and other genes, diseases, pathways and post-translational modifications.